Skip to main content

Peer Review reports

From: Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Original Submission
29 May 2022 Submitted Original manuscript
13 Jul 2022 Reviewed Reviewer Report
12 Aug 2022 Reviewed Reviewer Report
26 Aug 2022 Author responded Author comments - Tetsuya Isaka
Resubmission - Version 2
26 Aug 2022 Submitted Manuscript version 2
5 Sep 2022 Editorially accepted
9 Sep 2022 Article published 10.1186/s12885-022-10057-w

You can find further information about peer review here.

Back to article page